The Medical Management in Patients Exposed to Weapons of Mass Destruction
Launched by ST. JUSTINE'S HOSPITAL · Aug 23, 2021
Trial Information
Current as of July 25, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This is an ongoing multicentric observational study that aims to assess the medical response to chemical, biological, radiological, nuclear, explosive (cbrne) events during the last five (5) decades (i.e.: 1970-2020), and in any future cbrne attack that might occur within the next 15 years (i.e.: 2021-2036). Of note, the data collection will be performed retrospectively and after sites review ethic board (REB) approval.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • i. a CBRNE attack caused at least one casualty who required the assistance of the participating health care system (e.g.: physicians, nurses, paramedics and other health-care specialists of a medical facility) during a medical extraction from the incident site until admission to a medical facility;
- • ii. Patients are eligible if they were exposed to the CBRNE attack;
- • iii. Medical information concerning the CBRNE exposures, even if partial, is accessible to health care professionals for the purposes of filling out the online case report form (eCRF);
- • iv. Participants must be able to complete the online case report form in English; and
- • v. The approval of an Ethics Review Board is obtained by each medical centre participant.
- Exclusion Criteria:
- • A negative response to any of the inclusion criteria results in an exclusion.
About St. Justine's Hospital
St. Justine's Hospital is a leading pediatric healthcare institution dedicated to advancing child health through innovative clinical research. Renowned for its commitment to excellence in patient care and medical education, the hospital serves as a vital center for clinical trials aimed at improving therapeutic options for children. With a multidisciplinary team of experts, St. Justine's Hospital leverages cutting-edge technology and evidence-based practices to facilitate groundbreaking studies that address a wide range of pediatric conditions, ensuring the highest standards of safety and efficacy for its young patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Quebec, , Canada
Winnipeg, Manitoba, Canada
Ottawa, Ontario, Canada
Montreal, Quebec, Canada
Quebec, , Canada
Paris, Ile De France, France
Tokyo, Shinjuku Ku, Japan
Winnipeg, Manitoba, Canada
Winnipeg, Manitoba, Canada
Montreal, Quebec, Canada
Montreal, Quebec, Canada
Sherbrooke, Quebec, Canada
Quebec, , Canada
Tokyo, , Japan
Tokyo, , Japan
College Park, Maryland, United States
Tokyo, , Japan
Tokyo, , Japan
Montréal, Quebec, Canada
Prague, , Czechia
Surrey Quays, Redhill, United Kingdom
Winchester, , United Kingdom
Patients applied
Trial Officials
Stephane Bourassa
Principal Investigator
Ste-Justine's Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials